Rodger Novak - Insider Trading & Ownership

Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Summary
The estimated net worth of Rodger Novak is at least $35.8M dollars as of July 1, 2021. Rodger Novak is the President, Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $35.8M.
Signature
/s/ Michael Esposito, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Rodger Novak

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG President, Director $35.8M Jun 30, 2021

Insider Transactions Reported by Rodger Novak:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.